Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | New Market Research Report: Lithuania Pharmaceuticals & Healthcare Report Q3 2010Fast Market Research recommends "Lithuania Pharmaceuticals & Healthcare Report Q3 2010" from Business Monitor International, now available
In fact, we expect Lithuania's pharmaceutical market to face a drawn-out recovery, following the severe disruption the deep economic contraction had on spending in 2009. For the year, BMI calculates that total pharmaceutical sales decreased by 3.9% year-on-year (y-o-y) in local currency (or by 9.9% in US dollars), to a value of LTL1.64bn (US$0.63bn). The outlook for the country's pharmaceutical sales in 2010 is slightly more optimistic, with BMI expecting pharmaceutical spending to grow by 1.3%, although continued negative currency fluctuations are likely to result in further contractions in US dollars. Prevailing poor performance will be driven by fiscal austerity and increasingly negative market access policies, with the five-year outlook for Lithuania's pharmaceutical market appearing relatively bleak. On the economic front, we maintain our core view that deflation in Lithuania will remain firmly in play through the first half of 2010, as the economy's ongoing 'internal devaluation' forces wages, output and prices to adjust to the downside. Moreover, given our poor growth outlook for the Baltic economy over the medium term, we believe inflationary pressures will remain weak well into 2011 and forecast consumer price inflation coming in at 0.2% and 2.5% at end-2010 and 2011 respectively, which will also have a bearing on the development of the pharmaceutical market values. In the meantime, demand for some treatments may be increased by the prevailing economic conditions. According to a recently-published scientific paper Health in Financial Crises: Economic Recession and Tuberculosis in Central and Eastern Europe, the Baltic States are vulnerable to an increase in tuberculosis (TB) cases and deaths as a result of the economic downturn. The research studied the relationship between lost economic productivity and excess TB cases and mortality, comparing the situation following the collapse of the Soviet Union with the current economic downturn. However, although the Baltic States may show some susceptibility to an increase in TB SDRs, we note that the overall economic, political and social situation is dramatically different from that of the early 1990s. Overall, BMI believes that a substantial increase in the number of TB SDRs is unlikely and that any increases will be confined to a small demographic. For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: Executive Summary SWOT Analysis - Lithuania Pharmaceuticals And Healthcare Industry SWOT - Lithuania Political SWOT - Lithuania Economic SWOT - Lithuania Business Environment SWOT Pharmaceutical Business Environment Ratings - Table: Emerging Europe Pharmaceutical Business Environment Ratings, Q310 - Limits of Potential Returns - Risk to Realisation of Returns - Lithuania - Market Summary Regulatory Regime - Baltic Collaboration - Intellectual Property Developments - Pricing Regime - Recent Pricing Developments - Reimbursement Regime - Recent Reimbursement Developments Industry Developments - Epidemiology - Table: Disease Burden In CEE - Recent Public Health Developments - Healthcare System - Healthcare Funding - Healthcare Insurance - Pharmaceutical Wholesale - Pharmaceutical Retail - Recent Pharmaceutical Distribution Developments - Clinical Trials - Medical Devices Industry Forecast Scenario - Overall Market Forecast - Key Growth Factors - Industry - Key Growth Factors - Macroeconomic - Table: Lithuania - Economic Activity - Prescription Drug Market Forecast - Patented Drug Market Forecast - Generic Drug Market Forecast - OTC Medicine Market Forecast - Pharmaceutical Trade Forecast - Other Healthcare Data Forecasts - Key Risks to BMI's Forecast Scenario Competitive Landscape - Pharmaceutical Sector - Domestic Industry - Table: Drugmakers, Distributors And Retailers Active In The Baltic States, Q207 - Biotechnology Company Profiles - Indigenous Company Profiles - Valentis - Sanitas - Sicor Biotech - Multinational Company Profiles - GlaxoSmithKline - Pfizer - Novartis - Merck & Co - Sanofi-Aventis Country Snapshot: Lithuania Demographic Data - Section 1: Population - Table: Demographic Indicators, 2005-2030 - Table: Rural/Urban Breakdown, 2005-2030 - Section 2: Education And Healthcare - Table: Education, 2002-2005 - Table: Vital Statistics, 2005-2030 - Section 3: Labour Market and Spending Power - Table: Employment Indicators, 2001-2006 - Table: Consumer Expenditure, 2000-2012 (US$) - Table: Average Annual Wages, 2000-2012 Full Table of Contents is available at: -- http://www.fastmr.com/ About Business Monitor International Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number